Market News (Page 15) - TendieTensor

Market News Page 15 of 279 • 6,951 articles

Bronstein, Gewirtz & Grossman LLC Urges Freeport-McMoRan Inc. Investors to Act: Class Action Filed Alleging Investor Harm

GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc

Bronstein, Gewirtz & Grossman LLC Urges Freeport-McMoRan Inc. Investors to Act: Class Action Filed Alleging Investor Harm

01/07/2026 12:00 PM • A class action lawsuit has been filed against Freeport-McMoRan Inc. alleging that the company made false and misleading statements regarding safety practices at its Grasberg Block Cave mine in Indonesia. The lawsuit claims defendants failed to disclose inadequate safety measures and the heightened risk of worker deaths, regulatory action, and reputational damage. The class period covers purchases between February 15, 2022 and September 24, 2025, with a lead plaintiff deadline of January 12, 2026.

BRK.A - Making a strategic tech investment that deviates from traditional portfolio, potentially signaling leadership transition
FCX - The company is the defendant in a securities fraud class action alleging material misstatements about safety practices at its Indonesian mining operations, failure to disclose worker safety risks, and resulting regulatory and reputational exposure. These allegations directly harm investor confidence and shareholder value.

#class action lawsuit #securities fraud #Grasberg Block Cave mine #safety violations #investor damages #Indonesia

GENFIT Announces 2026 Financial Calendar

GlobeNewswire Inc. • Genfit

GENFIT Announces 2026 Financial Calendar

01/07/2026 12:00 PM • GENFIT, a biopharmaceutical company focused on rare liver diseases, announced its provisional 2026 financial calendar with key dates for earnings releases, annual shareholder meeting on June 15, and publication of financial statements. The company continues development of its lead asset G1090N for ACLF and GNS561 for cholangiocarcinoma, with Iqirvo® (elafibranor) already approved and marketed for Primary Biliary Cholangitis.

GOOGL - Berkshire's investment signals confidence, stock is considered cheap with strong earnings potential, and has grown 53% year-to-date
IPSEY - Ipsen holds an 8% stake in GENFIT and commercializes Iqirvo® (elafibranor) in major markets including the U.S. and Europe. The drug's successful FDA/EMA approvals and market expansion represent revenue opportunities and validate Ipsen's investment in GENFIT's pipeline.

#financial calendar #liver diseases #ACLF #cholangiocarcinoma #Iqirvo #elafibranor #clinical trials #FDA approval #biopharmaceutical

Bronstein, Gewirtz & Grossman LLC Urges F5, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc

Bronstein, Gewirtz & Grossman LLC Urges F5, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

01/07/2026 12:00 PM • A class action lawsuit has been filed against F5, Inc. alleging that the company made materially false and misleading statements about its security capabilities while concealing a significant security breach affecting key products. Investors who purchased F5 securities between October 28, 2024 and October 27, 2025 are encouraged to join the case, with a lead plaintiff deadline of February 17, 2026.

FFIV - The company is accused of making false statements about security capabilities while concealing a significant security breach affecting key products. This resulted in investors purchasing securities at artificially inflated prices, indicating serious corporate misconduct and potential financial harm to shareholders.

#class action lawsuit #securities fraud #security breach #investor harm #materially false statements #artificially inflated prices

VALLOUREC INITIATES A €200 MILLION SHARE BUYBACK AND TARGETS TOTAL SHAREHOLDER RETURN TO BE AT LEAST €500 MILLION BY AUGUST 2026

GlobeNewswire Inc. • Na

VALLOUREC INITIATES A €200 MILLION SHARE BUYBACK AND TARGETS TOTAL SHAREHOLDER RETURN TO BE AT LEAST €500 MILLION BY AUGUST 2026

01/07/2026 12:00 PM • Vallourec announced a €200 million share buyback program through June 2026 to cover warrant dilution and service employee incentive plans. The company also plans to return approximately €300 million from warrant exercise proceeds plus 80-100% of 2025 cash generation through an extraordinary interim dividend in Q3 2026, targeting total shareholder returns of at least €500 million. No annual dividend for 2025 is planned.

BRK.B - Purchased over 17.8 million Alphabet shares, indicating confidence in the tech company's future
VLOWY - The company is demonstrating shareholder-friendly capital allocation through a substantial €200 million buyback program and commitment to €500 million in total shareholder returns by August 2026. This reflects confidence in the company's financial position and stock valuation, while maintaining disciplined leverage and liquidity constraints. The initiative aligns with management's strategy to enhance returns on capital and position Vallourec as a shareholder-friendly company within its peer group.

#share buyback #shareholder returns #warrant exercise #interim dividend #capital allocation #dilution reduction

GENFIT annonce son calendrier financier pour 2026

GlobeNewswire Inc. • Genfit

GENFIT annonce son calendrier financier pour 2026

01/07/2026 12:00 PM • GENFIT, a clinical-stage biopharmaceutical company focused on rare liver diseases, announced its 2026 financial calendar with key publication dates for revenue, financial results, and shareholder meetings. The company continues development of its lead asset G1090N for acute-on-chronic liver failure with favorable Phase 1 safety data, and GNS561 showing promising antitumor activity in cholangiocarcinoma combination therapy.

BRK.A - Purchased over 17.8 million Alphabet shares, indicating confidence in the tech company's future
IPSEY - Ipsen is mentioned as a major shareholder (8% stake since 2021) and commercializes Iqirvo® (elafibranor) in multiple countries. While this represents a commercial partnership, the article provides no specific updates on Ipsen's performance or commercial results, warranting a neutral stance.

#financial calendar 2026 #rare liver diseases #G1090N #ACLF #GNS561 #cholangiocarcinoma #clinical development #Iqirvo #elafibranor

VALLOUREC LANCE UN PROGRAMME DE RACHAT D’ACTIONS DE 200MILLIONS D’EUROS ET VISE UN RETOUR TOTAL AUX ACTIONNAIRES D’AU MOINS 500MILLIONS D’EUROS D’ICI AOUT 2026

GlobeNewswire Inc. • Na

VALLOUREC LANCE UN PROGRAMME DE RACHAT D’ACTIONS DE 200MILLIONS D’EUROS ET VISE UN RETOUR TOTAL AUX ACTIONNAIRES D’AU MOINS 500MILLIONS D’EUROS D’ICI AOUT 2026

01/07/2026 12:00 PM • Vallourec announced a €200 million share buyback program running until June 30, 2026, aimed at covering warrant exercises and reducing dilution. The company also plans to distribute approximately €300 million from warrant exercises plus excess 2025 cash generation as an exceptional interim dividend in Q3 2026, targeting total shareholder returns of at least €500 million in 2026. No annual dividend for 2025 is planned.

GOOGL - Stock price increased by 3%, Berkshire Hathaway investment, strong AI initiatives, and reasonable valuation
VLOWY - The company is demonstrating strong capital allocation discipline with a substantial €500 million shareholder return commitment, indicating confidence in financial performance and cash generation. The buyback program and exceptional dividend signal management's conviction in the stock's valuation potential and commitment to improving shareholder value while maintaining a conservative leverage ratio of ±0.5x net debt/EBITDA.

#share buyback #shareholder returns #warrant exercises #interim dividend #capital allocation #cash generation #dilution reduction

Critical Metals Stock Rallies 80%: The Trump Factor

Benzinga • Erica Kollmann

Critical Metals Stock Rallies 80%: The Trump Factor

01/07/2026 11:57 AM • Critical Metals (NASDAQ: CRML) stock surged 80% over the past week amid speculation about President Trump's interest in Greenland and support for rare earth independence. The rally is driven by the company's Tanbreez Rare Earth Project in Greenland, one of the world's largest rare earth deposits outside China. Critical Metals announced the start of construction for a storage and pilot-plant facility in Greenland, positioning itself as a Western-aligned solution to reduce reliance on Chinese rare earth supplies.

BRK.B - Making a strategic tech investment that deviates from traditional portfolio, potentially signaling leadership transition
CRML - 80% stock rally over one week driven by Trump's Greenland ambitions, major Tanbreez rare earth project in Greenland, formal approval of construction, and positioning as a Western alternative to Chinese rare earth dominance.

#rare earth elements #Greenland #Trump administration #critical minerals #national security #Tanbreez project #China monopoly

Bank Of America's Top 3 Commodity Stock Picks For 2026

Benzinga • Piero Cingari

Bank Of America's Top 3 Commodity Stock Picks For 2026

01/07/2026 11:55 AM • Bank of America recommends three commodity stocks for 2026: Agnico Eagle Mines (gold), Cameco (uranium), and Freeport-McMoRan (copper). The firm forecasts gold averaging $4,538/oz (up 32% YoY), uranium at $105/lb (up 43% YoY), and copper at $5.33/lb (up 18% YoY), driven by U.S. industrial policy, a weaker dollar, geopolitical tensions, and tariff uncertainty.

AEM - Bank of America set a $227 price target implying 26% upside, citing consistent execution, compelling growth potential, low-risk Canadian assets, and unwarranted share price weakness. Gold forecast of $4,538/oz represents 32% YoY growth.

#commodity stocks #gold #uranium #copper #mining #2026 outlook #industrial policy #price forecasts

GSK/Ionis Partnered Investigational Drug Shows Strong Results In Large Hepatitis B Studies

Benzinga • Vandana Singh

GSK/Ionis Partnered Investigational Drug Shows Strong Results In Large Hepatitis B Studies

01/07/2026 11:48 AM • GSK and Ionis Pharmaceuticals announced positive Phase 3 trial results for bepirovirsen, an investigational antisense oligonucleotide for chronic hepatitis B. The B-Well 1 and B-Well 2 studies, involving over 1,800 patients, met their primary endpoint with statistically significant functional cure rates. If approved, bepirovirsen could become the first finite, six-month therapeutic option for CHB. Regulatory submissions are planned for Q1 2026.

GSK - GSK's partnered drug met primary endpoints in large Phase 3 studies with clinically meaningful results, supporting potential regulatory approval and market opportunity for a novel hepatitis B treatment.

#hepatitis B #bepirovirsen #Phase 3 trials #antisense oligonucleotide #functional cure #chronic hepatitis B #regulatory approval

Crisis in the Caribbean: The Defense Sector Playbook

Investing.com • Jeffrey Neal Johnson

Crisis in the Caribbean: The Defense Sector Playbook

01/07/2026 11:40 AM • Following U.S. military operations in Venezuela after the collapse of the Argyle Accords, the aerospace and defense sector is experiencing strategic rotation. Rather than broad defense stock purchases, investors should focus on companies addressing critical needs: ammunition replenishment and regional border security. RTX Corp and L3Harris benefit from depleted global inventories and pricing power, while Embraer capitalizes on Brazil's border security operations. Supply chain constraints in titanium and other materials remain a key risk.

RTX - Record $225 billion backlog, removed DOJ regulatory overhang, strong pricing power due to global inventory depletion in Eastern Europe and Middle East, inelastic demand ensures revenue visibility through end of decade

#Venezuela conflict #aerospace and defense #military operations #ammunition replenishment #border security #supply chain constraints #geopolitical risk #defense contractors

Is the AI Supercycle Really Just Beginning?

The Motley Fool • Dan Caplinger

Is the AI Supercycle Really Just Beginning?

01/07/2026 11:35 AM • The article argues that the AI supercycle is still in its early stages despite strong 2025 performance from major tech companies. While companies like Alphabet and Nvidia saw significant gains, the real opportunities may lie with lesser-known suppliers and infrastructure providers supporting AI development. With AI spending projected to exceed $2 trillion in 2026 and major data center projects coming online, companies providing power, cooling, connectivity, and hardware could be the long-term winners, similar to how infrastructure suppliers benefited from the internet boom.

BULLW - Down over 25% in past month, RSI of 24.06 suggests potential price correction
GOOG - Strong 2025 performance with 59% gain and nearly $1.5 trillion added to market cap; positioned as a major AI developer and implementer

#AI supercycle #artificial intelligence stocks #infrastructure investment #data centers #hyperscalers #technology spending #long-term investment

Despite Bubble Fears, 93% of AI Investors Say They're Bullish on Long-Term Returns. Here Are 2 Stocks to Hold for a Decade or More.

The Motley Fool • Robert Izquierdo

Despite Bubble Fears, 93% of AI Investors Say They're Bullish on Long-Term Returns. Here Are 2 Stocks to Hold for a Decade or More.

01/07/2026 11:35 AM • A survey shows 93% of AI investors remain bullish on long-term AI sector returns despite bubble concerns. The article recommends Nvidia and Alphabet as two stocks positioned for decade-long growth, citing Nvidia's strong revenue growth driven by AI infrastructure demand and Alphabet's success in maintaining search dominance while expanding AI capabilities across multiple business units including autonomous vehicles.

BULL - Down over 25% in past month, RSI of 24.06 suggests potential price correction
NVDA - Strong revenue growth (62% YoY to $57B in Q3 FY2026), positioned as leader in AI infrastructure with GPU demand, expanding into emerging fields like agentic AI and autonomous vehicles, strategic partnerships with Uber for autonomous vehicle deployment by 2027.

#artificial intelligence #AI bubble #long-term returns #semiconductor chips #generative AI #autonomous vehicles #investor sentiment

Vishay Intertechnology Transmissive Sensors Offer Greater Vertical Headroom and Design Flexibility for Industrial and Consumer Applications

GlobeNewswire Inc. • Vishay Intertechnology, Inc.

Vishay Intertechnology Transmissive Sensors Offer Greater Vertical Headroom and Design Flexibility for Industrial and Consumer Applications

01/07/2026 11:00 AM • Vishay Intertechnology has expanded its transmissive sensor family with two new surface-mount devices (VT171P single-channel and VT172U dual-channel) featuring a 42% increased dome height compared to previous-generation devices. These compact sensors are designed for position sensing, optical encoding, and motion detection applications across industrial, consumer, and telecom markets, with samples and production quantities available now.

VSH - The company is expanding its product portfolio with new transmissive sensors featuring improved specifications (42% increased dome height), offering greater design flexibility and broader application possibilities. The devices are available for immediate sampling and production, indicating successful product development and market readiness.

#transmissive sensors #surface-mount devices #position sensing #optical encoding #infrared emitter #phototransistor detector #industrial automation #VT171P #VT172U #compact package

JLL Adopts ARGUS Intelligence as Continuation of Existing Partnership

GlobeNewswire Inc. • Altus Group Limited

JLL Adopts ARGUS Intelligence as Continuation of Existing Partnership

01/07/2026 11:00 AM • Jones Lang LaSalle (JLL) has renewed its relationship with Altus Group to use ARGUS Intelligence for valuation requirements across its Capital Markets & Investment Services businesses globally. The expanded agreement includes an asset-based licensing model and exploration of advanced performance analysis tools, alongside Altus' Forbury product already in use in Australia.

JLL - The renewal of an existing partnership is a routine business decision that maintains operational continuity. While it shows confidence in Altus' products, it represents a continuation rather than a significant new development for JLL.

#commercial real estate #ARGUS Intelligence #valuation #partnership renewal #capital markets #performance analytics

Advanced Ceramics Market Size is Expected to Reach USD 175.80 Billion by 2033 Owing to the Rising Demand for High-Performance Materials Across Industries Globally | SNS Insider

GlobeNewswire Inc. • Sns Insider

Advanced Ceramics Market Size is Expected to Reach USD 175.80 Billion by 2033 Owing to the Rising Demand for High-Performance Materials Across Industries Globally | SNS Insider

01/07/2026 11:00 AM • The global advanced ceramics market is projected to grow from USD 110.26 billion in 2025 to USD 175.80 billion by 2033, at a CAGR of 6.07%. Growth is driven by rising demand for high-performance materials in electronics, automotive, aerospace, and healthcare sectors. Asia Pacific leads the market with 41.64% share, while North America shows the fastest growth trajectory.

MMM - 3M joined the US-JOINT Consortium in Feb 2025 to advance next-generation semiconductor packaging technologies, demonstrating active innovation and strategic positioning in the growing advanced ceramics market.

#advanced ceramics #market growth #high-performance materials #semiconductors #aerospace #electronics #healthcare #structural ceramics #functional ceramics #oxide ceramics

Offsite Data Center Power Infrastructure Market Projected to Reach US$ 79.76 Billion by 2035, Supported by Long-Term Power Procurement Strategies Says Astute Analytica

GlobeNewswire Inc. • Astute Analytica

Offsite Data Center Power Infrastructure Market Projected to Reach US$ 79.76 Billion by 2035, Supported by Long-Term Power Procurement Strategies Says Astute Analytica

01/07/2026 11:00 AM • The global offsite data center power infrastructure market is experiencing hyper-growth, valued at USD 15.9 billion in 2025 and projected to reach USD 79.76 billion by 2035 at a 17.50% CAGR. Growth is driven by AI computational demands, chip architecture changes (NVIDIA's Blackwell B200), nuclear power deals, and supply chain constraints. Major tech companies are deploying record capital expenditures, with Microsoft allocating USD 80 billion and Amazon USD 75 billion for infrastructure in 2024-2025.

MSFT - Allocating record USD 80 billion for data center and AI infrastructure in FY2025, signed 20-year nuclear power agreement with Constellation Energy for 835 MW, and partnering with Brookfield Renewable for USD 10 billion capacity development. Strong capital deployment signals market confidence.

#data center power infrastructure #AI computational demands #NVIDIA Blackwell B200 #nuclear power procurement #capital expenditure #supply chain constraints #renewable energy #grid independence

GPK Investors Have Opportunity to Join Graphic Packaging Holding Company Fraud Investigation with the Schall Law Firm

GlobeNewswire Inc. • Schall Law Firm

GPK Investors Have Opportunity to Join Graphic Packaging Holding Company Fraud Investigation with the Schall Law Firm

01/07/2026 11:00 AM • The Schall Law Firm is investigating Graphic Packaging Holding Company for potential securities law violations following the company's December 8, 2025 announcement of lowered full-year core earnings and profit outlook. The announcement triggered an 8.6% stock price decline. Investors who suffered losses are encouraged to participate in the investigation.

GPK - The company issued false or misleading statements regarding earnings outlook, leading to significant stock price decline of 8.6% and triggering a fraud investigation. This indicates serious governance and disclosure concerns.

#securities fraud #shareholder litigation #earnings guidance #stock decline #investor losses #class action lawsuit

ROSEN, THE FIRST FILING FIRM, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AGL

GlobeNewswire Inc. • Rosen Law Firm

ROSEN, THE FIRST FILING FIRM, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AGL

01/07/2026 11:00 AM • Rosen Law Firm has filed a class action lawsuit against agilon health, inc. (NYSE: AGL) on behalf of investors who purchased securities between February 26, 2025 and August 4, 2025. The lawsuit alleges that defendants made false and misleading statements regarding 2025 guidance they knew would not be achieved, overstated financial impacts from strategic actions, and misrepresented the company's business and prospects. Investors have until March 2, 2026 to move the court if they wish to serve as lead plaintiff.

AGL - The company is the subject of a securities class action lawsuit alleging material misstatements regarding 2025 guidance, overstatement of financial impacts from strategic actions, and false representations about business operations and prospects. These allegations indicate serious corporate governance and disclosure failures that resulted in investor losses.

#securities class action #false statements #misleading guidance #investor compensation #lead plaintiff deadline

Cloud-Based Quantum Computing Market is expected to generate a revenue of USD 55.22 Billion by 2031, Globally, at 38% CAGR: Verified Market Research®

GlobeNewswire Inc. • Verified Market Research®

Cloud-Based Quantum Computing Market is expected to generate a revenue of USD 55.22 Billion by 2031, Globally, at 38% CAGR: Verified Market Research®

01/07/2026 11:00 AM • The global cloud-based quantum computing market is projected to grow from USD 5.8 billion in 2024 to USD 55.22 billion by 2031, expanding at a 38% CAGR. Growth is driven by rising demand for enhanced computational power, expanding cloud infrastructure, and strategic investments in quantum technologies. However, challenges include high initial costs, limited talent pool, technological complexity, and data security concerns.

MSFT - Identified as a key industry leader offering scalable quantum solutions through Microsoft Azure, contributing to market accessibility and adoption.

#quantum computing #cloud-based computing #market growth #computational power #quantum algorithms #data security #technological innovation

eInfochips Named “IoT Development Service Provider of the Year” at 2026 IoT Breakthrough Awards

GlobeNewswire Inc. • Na

eInfochips Named “IoT Development Service Provider of the Year” at 2026 IoT Breakthrough Awards

01/07/2026 10:00 AM • eInfochips, an Arrow Electronics company, has been recognized as 'IoT Development Service Provider of the Year' at the 10th annual IoT Breakthrough Awards. The company provides end-to-end IoT solutions including consulting, system integration, and analytics, with over 750 products developed and 100 million deployments across 140 countries.

ARW - As the parent company of eInfochips, Arrow Electronics benefits from the subsidiary's award recognition and demonstrated innovation in IoT services. The award reflects positively on Arrow's engineering and design services division.

#IoT #Internet of Things #engineering services #IoT solutions #digital transformation #edge-to-cloud #IoT accelerators #industrial IoT

Trends and Demand in Thermoformed Trays Market 2025-35

GlobeNewswire Inc. • Towards Packaging

Trends and Demand in Thermoformed Trays Market 2025-35

01/07/2026 10:00 AM • The global thermoformed trays market is expected to grow from USD 12.67 billion in 2025 to USD 32.57 billion by 2034, with a CAGR of 9.9%. Growth is driven by increasing demand for lightweight, sustainable, and durable packaging across food, medical, and consumer goods industries. Key trends include adoption of biodegradable materials, automation technologies, smart packaging solutions, and custom designs. North America leads the market while Asia Pacific shows rapid expansion.

AMCR - Company expanded thermoforming capabilities in North America and Europe and launched AmSecure APET-based trays for healthcare applications, demonstrating strategic growth investments and innovation in high-demand market segments.

#thermoformed trays #sustainable packaging #biodegradable plastics #food packaging #pharmaceutical packaging #market growth #automation #smart packaging #PET trays #healthcare packaging

5 Drone Stocks Poised for Liftoff in 2026

Investing.com • Jesse Cohen

5 Drone Stocks Poised for Liftoff in 2026

01/07/2026 09:48 AM • The drone industry is experiencing explosive growth driven by military demand, AI-powered autonomy, and expanding commercial applications. Five companies are highlighted as strong investment opportunities: AeroVironment dominates tactical drones with 20% upside potential; Textron offers balanced drone exposure with 28% upside; Kratos Defense excels in AI-powered military drones with 63% upside; Ondas provides critical drone connectivity infrastructure with strong growth projections; and Red Cat Holdings is a small-cap disruptor in counter-drone technology with 10-65% upside potential.

AVAV - Dominates military and small UAS sector with flagship products seeing heavy Pentagon demand. Strong analyst consensus with 20% upside to $383 price target by 2026. Solid financial health score of 2.21 and expanding into AI-driven autonomous systems.

#drone stocks #unmanned aerial vehicles #defense spending #AI autonomy #military technology #commercial drones #drone connectivity

Why Lloyds Is Betting On Blockchain, Not Crypto Speculation

Benzinga • Hillary Remy

Why Lloyds Is Betting On Blockchain, Not Crypto Speculation

01/07/2026 09:46 AM • Lloyds Banking Group is aggressively adopting blockchain technology for operational efficiency rather than crypto speculation. The bank plans to roll out tokenized deposits by mid-2027, which could revolutionize mortgage processing and settlement times. This institutional approach to blockchain contrasts with decentralized finance platforms, as traditional banks leverage blockchain while maintaining regulatory oversight and consumer protections.

LYG - Lloyds is positioned as a leader in institutional blockchain adoption with concrete plans for tokenized deposit rollout by 2027, successful pilot programs, and landmark transactions demonstrating practical blockchain applications.

#blockchain adoption #tokenized deposits #institutional finance #real world asset tokenization #traditional finance vs DeFi #mortgage processing #regulatory compliance

Should You Invest $100 in SoFi Technologies Right Now?

The Motley Fool • John Ballard

Should You Invest $100 in SoFi Technologies Right Now?

01/07/2026 09:35 AM • SoFi Technologies surged 70% in 2025 and shows strong growth prospects with earnings more than doubling year-over-year in Q3. The fintech company's financial services segment grew 76% YoY, driven by growth in banking, brokerage, credit, and loans. With membership up 35% and investments in blockchain and AI, analysts project 30% annualized earnings growth through 2029, though the stock trades at a premium 51x earnings valuation.

SOFI - Strong earnings growth (doubled YoY in Q3), robust revenue growth in financial services segment (76% YoY), significant membership growth (35% YoY), strategic investments in emerging technologies (blockchain, AI), and analyst projections of 30% annualized earnings growth through 2029 support a positive outlook despite elevated valuation multiples.

#fintech #growth stock #earnings acceleration #blockchain #artificial intelligence #financial services #membership growth

Big Flavor, Zero Compromise: Modelo® Debuts First-Ever Non-Alcoholic Option

GlobeNewswire Inc. • Constellation Brands

Big Flavor, Zero Compromise: Modelo® Debuts First-Ever Non-Alcoholic Option

01/07/2026 09:00 AM • Modelo, the No. 1 beer brand in the U.S., has launched its first non-alcoholic offering: Modelo Chelada Limón y Sal Non-Alcoholic. The product features 60 calories per 12 oz. can and is now available in leading markets nationwide. The launch capitalizes on growing consumer demand for moderation and flavorful non-alcoholic beverages, with the low and non-alcoholic chelada segment forecasted to expand 50% over the next 24 months.

STZ - The company is successfully expanding its portfolio with a first-mover non-alcoholic offering in a high-growth segment (50% forecasted expansion). The product leverages the brand's existing strength (Modelo Chelada is the leading RTD Michelada for six years) and addresses powerful consumer trends (moderation and flavor). This strategic innovation positions Constellation Brands to capture growing demand in the non-alcoholic beverage category.

#non-alcoholic beer #product innovation #Modelo Chelada #mindful drinking #market expansion #consumer trends